Eden Research (LON:EDEN) Shares Pass Above Fifty Day Moving Average – Time to Sell?

Eden Research plc (LON:EDEN)’s stock price crossed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of GBX 2.93 ($0.04) and traded as high as GBX 4.40 ($0.06). Eden Research shares last traded at GBX 4 ($0.05), with a volume of 768,905 shares.

Eden Research Stock Down 3.7%

The company has a debt-to-equity ratio of 1.26, a quick ratio of 2.42 and a current ratio of 3.80. The firm has a market cap of £20.80 million, a PE ratio of -13.66 and a beta of 0.92. The stock has a fifty day moving average price of GBX 2.93 and a 200-day moving average price of GBX 3.45.

Eden Research (LON:EDEN) last issued its earnings results on Tuesday, May 6th. The company reported GBX (0.36) ($0.00) EPS for the quarter. Eden Research had a negative net margin of 38.70% and a negative return on equity of 11.63%. Research analysts expect that Eden Research plc will post -66.0000038 EPS for the current year.

Insider Activity

In other news, insider Alexander John Abrey acquired 167,947 shares of the company’s stock in a transaction dated Tuesday, March 4th. The shares were bought at an average price of GBX 3 ($0.04) per share, for a total transaction of £5,038.41 ($6,762.97). Also, insider Sean M. Smith acquired 426,986 shares of the company’s stock in a transaction dated Tuesday, April 1st. The shares were purchased at an average price of GBX 234 ($3.14) per share, for a total transaction of £999,147.24 ($1,341,137.23). Insiders own 14.02% of the company’s stock.

About Eden Research

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.